Upregulation of Vascular Angiotensin II Receptor Gene Expression by Low-Density Lipoprotein in Vascular Smooth Muscle Cells

作者: G. Nickenig , A. Sachinidis , F. Michaelsen , M. Bo¨hm , S. Seewald

DOI: 10.1161/01.CIR.95.2.473

关键词: Downregulation and upregulationLow-density lipoproteinAngiotensin II receptor type 1Internal medicineBiologyVascular smooth muscleAngiotensin receptorEndocrinologyAngiotensin IIReceptorVascular disease

摘要: Background Because LDL and the angiotensin II type 1 (AT1) receptor are thought to be involved in pathogenesis of chronic vascular disease, we studied possible interactions between these two biological systems cultured rat smooth muscle cells. Methods Results Incubation cells with 100 μg/mL profoundly increased AT1 mRNA ≈250% control levels as assessed by Northern hybridization analysis. This effect is maximal 12 hours after addition culture medium sustained for up 24 hours. The LDL-induced upregulation dose dependent, a obtained LDL. There correlative increase cell surface–associated receptors saturation radioligand binding assays. half-life substantially compared that treated only 5,6-dichlorobenzimidazole block transcription. Angiotensin II–induced elevation cytosolic calcium concen...

参考文章(52)
Richard L. Soffer, Biochemical regulation of blood pressure Wiley. ,(1981)
B.C. Berk, M.S. Aronow, T.A. Brock, E. Cragoe, M.A. Gimbrone, R.W. Alexander, Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways. Journal of Biological Chemistry. ,vol. 262, pp. 5057- 5064 ,(1987) , 10.1016/S0021-9258(18)61153-6
M J Peach, Renin-angiotensin system: biochemistry and mechanisms of action. Physiological Reviews. ,vol. 57, pp. 313- 370 ,(1977) , 10.1152/PHYSREV.1977.57.2.313
J H Campbell, A Bobik, Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacological Reviews. ,vol. 45, pp. 1- 42 ,(1993)
K K Griendling, B Lassègue, T J Murphy, M Clark, R W Alexander, G Nickenig, Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Molecular Pharmacology. ,vol. 48, pp. 601- 609 ,(1995)
J. Chamley-Campbell, G. R. Campbell, R. Ross, The smooth muscle cell in culture Physiological Reviews. ,vol. 59, pp. 1- 61 ,(1979) , 10.1152/PHYSREV.1979.59.1.1
Stephen Gunther, Michael A. Gimbrone, R. Wayne Alexander, Regulation by angiotensin II of its receptors in resistance blood vessels Nature. ,vol. 287, pp. 230- 232 ,(1980) , 10.1038/287230A0
T. J. Murphy, R. Wayne Alexander, Kathy K. Griendling, Marschall S. Runge, Kenneth E. Bernstein, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor Nature. ,vol. 351, pp. 233- 236 ,(1991) , 10.1038/351233A0
Leif S. Jacobsson, Karin Persson, Gunnar Aberg, Rolf G. G. Andersson, Bengt E. Karlberg, Anders G. Olsson, Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs Journal of Cardiovascular Pharmacology. ,vol. 24, pp. 670- 677 ,(1994) , 10.1097/00005344-199410000-00019